Anthropic in Talks for Massive $50B Funding Round at $900B Valuation Amid Explosive Revenue Growth
Anthropic, creator of the Claude AI assistant, is reportedly considering a $40-50 billion funding round at a valuation between $850-900 billion, with a board decision expected in May. The company's annual revenue run rate has surged dramatically from approximately $9 billion at the end of 2025 to over $30 billion recently, with current estimates closer to $40 billion, driven largely by AI coding capabilities through Claude Code and Cowork platforms. This potential raise would more than double Anthropic's February valuation of $380 billion and position it competitively with OpenAI's $852 billion valuation.
Skynet Chance (+0.04%): Massive capital infusion ($50B) into a leading AI company accelerates development of increasingly capable AI systems without corresponding evidence of proportional safety investment, marginally increasing risks of misaligned AI systems. The explosive revenue growth and expansion into critical sectors (finance, healthcare) suggests rapid deployment of powerful AI without sufficient time for safety validation.
Skynet Date (-1 days): The unprecedented funding scale and explosive revenue growth (9B to 40B in roughly 16 months) significantly accelerates AI capability development and deployment timelines. This capital enables faster scaling of compute resources and expansion into critical infrastructure sectors, compressing the timeline for potential AI control challenges to emerge.
AGI Progress (+0.04%): The dramatic revenue surge driven by AI coding capabilities demonstrates significant practical progress in complex reasoning and task automation, key AGI components. Anthropic's expansion trajectory and investor confidence at near-trillion-dollar valuations reflects market assessment that current systems are approaching economically transformative capabilities characteristic of near-AGI systems.
AGI Date (-1 days): The $50 billion capital injection provides unprecedented resources to scale compute infrastructure, research capabilities, and talent acquisition, directly accelerating AGI development timelines. The company's explosive growth and plans for rapid expansion into multiple complex domains (finance, healthcare, life sciences) suggests aggressive pursuit of general-purpose capabilities that compress the path to AGI.